Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inna Chervoneva

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Molecular Cancer Therapeutics|July 5, 2019
<i>In Vivo</i> ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in MelanomaIleine M Sanchez, Timothy J Purwin, Inna Chervoneva, et al.
Radiology|June 30, 2009
High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanomaAkira Yamamoto, Inna Chervoneva, Kevin L Sullivan, et al.
Molecular Cancer Therapeutics|June 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant MelanomaMcKenna Q Glasheen, Signe Caksa, Amelia G Young, et al.
Clinical Pharmacology and Therapeutics|June 18, 2019
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's DiseaseDaniel A Monti, George Zabrecky, Daniel Kremens, et al.
The Journal of Investigative Dermatology|May 12, 2020
Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase InhibitionMai Q Nguyen, Jessica L F Teh, Timothy J Purwin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Cell Death & Disease|March 27, 2019
CADM1 is a TWIST1-regulated suppressor of invasion and survivalEdward J Hartsough, Michele B Weiss, Shea A Heilman, et al.
Cancer Immunology Research|July 15, 2020
Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK InhibitorsJessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
Diabetes Technology & Therapeutics|October 6, 2017
Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in SwineJasmin R Hauzenberger, Brian R Hipszer, Channy Loeum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factorTakami Sato, David J Eschelman, Carin F Gonsalves, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|July 5, 2019
<i>In Vivo</i> ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in MelanomaIleine M Sanchez, Timothy J Purwin, Inna Chervoneva, et al.
Radiology|June 30, 2009
High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanomaAkira Yamamoto, Inna Chervoneva, Kevin L Sullivan, et al.
Molecular Cancer Therapeutics|June 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant MelanomaMcKenna Q Glasheen, Signe Caksa, Amelia G Young, et al.
Clinical Pharmacology and Therapeutics|June 18, 2019
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's DiseaseDaniel A Monti, George Zabrecky, Daniel Kremens, et al.
The Journal of Investigative Dermatology|May 12, 2020
Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase InhibitionMai Q Nguyen, Jessica L F Teh, Timothy J Purwin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Cell Death & Disease|March 27, 2019
CADM1 is a TWIST1-regulated suppressor of invasion and survivalEdward J Hartsough, Michele B Weiss, Shea A Heilman, et al.
Cancer Immunology Research|July 15, 2020
Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK InhibitorsJessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
Diabetes Technology & Therapeutics|October 6, 2017
Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in SwineJasmin R Hauzenberger, Brian R Hipszer, Channy Loeum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factorTakami Sato, David J Eschelman, Carin F Gonsalves, et al.
Pageof 15